|

Adebrelimab blank preparation plus S-1 and oxaliplatin. Clinical Trials

1 actively recruiting trial

Pipeline

Phase 3: 1

Top Sponsors

  • Shanghai Shengdi Pharmaceutical Co., Ltd1

Indications

  • Locally Advanced Gastric or Gastroesophageal Junction Cancer1
  • Cancer1

Other1 trial

Clinical Study of Adebrelimab Therapy in the Perioperative Treatment of Gastric Cancer or Gastroesophageal Junction Cancer
Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.